Efavirenz and psychosis: Is there a link?

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 7, 2012, Pages 687-688

  Manning, Todd G ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; CANNABIS; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; METHAMPHETAMINE; RISPERIDONE; ADENINE; BENZOXAZINE DERIVATIVE; DEOXYCYTIDINE; DRUG DERIVATIVE; EFAVIRENZ; EFAVIRENZ, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE DRUG COMBINATION; OXAZINE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACUTE PSYCHOSIS; ADULT; AGGRESSION; ANAMNESIS; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG ABUSE; DRUG SAFETY; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PARANOIA; PERSECUTORY DELUSION; VIRUS LOAD; DRUG COMBINATION; PSYCHOSIS;

ADENINE; ADULT; BENZOXAZINES; DEOXYCYTIDINE; DRUG COMBINATIONS; HIV INFECTIONS; HUMANS; MALE; OXAZINES; PHOSPHONIC ACIDS; PSYCHOSES, SUBSTANCE-INDUCED; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 84867907692     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867412450474     Document Type: Letter

References (5)

1. Atripla (2011) Patient information. Available at: www.packageinserts.bms. com/ppi/ppi-atripla.pdf (accessed 25March2012).
2. Kashuba AD. DHHS guidelines for the use of antiretroviral agents in patients with HIV-1 infection. University of Tennessee Advanced Studies in Pharmacy. 2008 ; 5: 97-104
3. Lochet P, Peyrière H, Lotthé A, et al. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Medicine. 2003 ; 4: 62-66 (Pubitemid 37161538)
4. Poulsen HD, Lublin HK. Efavirenz-induced psychosis leading to involuntary detention. AIDS. 2003 ; 17: 451-453 (Pubitemid 36223276)
5. Zalila H, Elloumi H, Gaha N, et al. Troubles psychotiques aigus sous efavirenz chez un patient atteint de HIV. La Tunisie Medicale. 2010 ; 88: 119-121